TAMPA, FL--(MARKET WIRE)--Jul 17, 2007 -- Stem Cell Therapy International, Inc. (OTC BB:SCII.OB - News) announced today that as reported in its 10KSB filing for the reporting period ending March 31, 2007 that it has increased revenues by 327% from its expanding stem cell treatment services over the comparable period in 2006. Calvin Cao, CEO of SCII.OB, went on to state, “Not only have we been able to increase revenues, but we have eliminated a significant cost of goods that will now save the company $120,000 per year over what had been paid in the past. We are very encouraged by our progress so far and look forward to exploring the numerous opportunities we have available for continued growth and expansion.”